American Journal of Neuroradiology 21:901-909 (5 2000)
© 2000 American Society of Neuroradiology
ARTICLE
Posttherapeutic Intraaxial Brain Tumor: The Value of Perfusion-sensitive Contrast-enhanced MR Imaging for Differentiating Tumor Recurrence from Nonneoplastic Contrast-enhancing Tissue
a From the Departments of Radiology (T.S., Y.K., S.T., Y.S., I.I., T.K., L.L., M.T.) and Neurosurgery (Y.U.), Kumamoto University School of Medicine, Japan.
BACKGROUND AND PURPOSE: Differentiation of tumor recurrence from treatment-related changes may be difficult with conventional MR imaging when newly enhancing lesions appear. Our aim was to determine the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating recurrent neoplasm from nonneoplastic contrast-enhancing tissue.
METHODS: Twenty patients in whom new enhancing lesions developed within irradiated regions were examined prospectively with perfusion-sensitive contrast-enhanced MR imaging. Twelve of them also underwent thallous chloride Tl 201 single-photon emission tomography (201Tl-SPECT). Normalized relative cerebral blood volume (rCBV) ratios and thallium indexes were evaluated to determine whether the new enhancing lesions were recurrent or not. Five instances of tumor recurrence and one of radiation necrosis were verified histologically; in the others, tumor recurrence was distinguished by lesions that progressively increased in size on serial MR examinations over at least 5 months, and nonneoplastic contrast-enhancing tissue was distinguished by lesions that disappeared or decreased in size on serial MR studies over at least 9 months.
RESULTS: When normalized rCBV ratios were higher than 2.6 or lower than 0.6, enhancing lesions were either recurrent (n = 5) or nonneoplastic contrast-enhancing tissue (n = 3), respectively. All nonneoplastic contrast-enhancing tissue had a low thallium index, whereas three of four recurrent lesions had a high index.
CONCLUSION: An enhancing lesion with a normalized rCBV ratio higher than 2.6 or lower than 0.6 may suggest tumor recurrence or nonneoplastic contrast-enhancing tissue, respectively. In these cases, further examination with 201Tl-SPECT may not be necessary. However, when the normalized rCBV ratio is between 0.6 and 2.6, 201Tl-SPECT may be useful in making the differentiation.
This article has been cited by other articles:
 |
|
 |
|
  R. Hourani, L.J. Brant, T. Rizk, J.D. Weingart, P.B. Barker, and A. Horska Can Proton MR Spectroscopic and Perfusion Imaging Differentiate Between Neoplastic and Nonneoplastic Brain Lesions in Adults? AJNR Am. J. Neuroradiol., February 1, 2008; 29(2): 366 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.K. Ellika, R. Jain, S.C. Patel, L. Scarpace, L.R. Schultz, J.P. Rock, and T. Mikkelsen Role of Perfusion CT in Glioma Grading and Comparison with Conventional MR Imaging Features AJNR Am. J. Neuroradiol., November 1, 2007; 28(10): 1981 - 1987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. M. Maia Jr, S. M. F. Malheiros, A. J. da Rocha, C. J. da Silva, A. A. Gabbai, F. A. P. Ferraz, and J. N. Stavale MR Cerebral Blood Volume Maps Correlated with Vascular Endothelial Growth Factor Expression and Tumor Grade in Nonenhancing Gliomas AJNR Am. J. Neuroradiol., April 1, 2005; 26(4): 777 - 783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Schmainda, S. D. Rand, A. M. Joseph, R. Lund, B. D. Ward, A. P. Pathak, J. L. Ulmer, M. A. Baddrudoja, and H. G. J. Krouwer Characterization of a First-Pass Gradient-Echo Spin-Echo Method to Predict Brain Tumor Grade and Angiogenesis AJNR Am. J. Neuroradiol., October 1, 2004; 25(9): 1524 - 1532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Covarrubias, B. R. Rosen, and M. H. Lev Dynamic Magnetic Resonance Perfusion Imaging of Brain Tumors Oncologist, September 1, 2004; 9(5): 528 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Matheus, M. Castillo, M. Ewend, J. K. Smith, L. Knock, S. Cush, and D. E. Morris CT and MR Imaging after Placement of the GliaSite Radiation Therapy System to Treat Brain Tumor: Initial Experience AJNR Am. J. Neuroradiol., August 1, 2004; 25(7): 1211 - 1217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Hein, C. J. Eskey, J. F. Dunn, and E. B. Hug Diffusion-Weighted Imaging in the Follow-up of Treated High-Grade Gliomas: Tumor Recurrence versus Radiation Injury AJNR Am. J. Neuroradiol., February 1, 2004; 25(2): 201 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Vazquez, A. Castellote, J. Piqueras, P. Ortuno, J. Sanchez-Toledo, P. Nogues, and J. Lucaya Second Malignancies in Pediatric Patients: Imaging Findings and Differential Diagnosis RadioGraphics, September 1, 2003; 23(5): 1155 - 1172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V Biousse, N J Newman, S B Hunter, and P A Hudgins Diffusion weighted imaging in radiation necrosis J. Neurol. Neurosurg. Psychiatry, March 1, 2003; 74(3): 382 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Eastwood, M. H. Lev, and J. M. Provenzale Perfusion CT with Iodinated Contrast Material Am. J. Roentgenol., January 1, 2003; 180(1): 3 - 12. [Full Text] [PDF]
|
|
|
|
|
|
K. Kikuchi, K. Murase, H. Miki, Y. Yasuhara, Y. Sugawara, T. Mochizuki, J. Ikezoe, and S. Ohue Quantitative Evaluation of Mean Transit Times Obtained with Dynamic Susceptibility Contrast-Enhanced MR Imaging and with 133Xe SPECT in Occlusive Cerebrovascular Disease Am. J. Roentgenol., July 1, 2002; 179(1): 229 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Uematsu, M. Maeda, N. Sadato, T. Matsuda, Y. Ishimori, Y. Koshimoto, H. Kimura, H. Yamada, Y. Kawamura, Y. Yonekura, et al. Blood Volume of Gliomas Determined by Double-Echo Dynamic Perfusion-Weighted MR Imaging: A Preliminary Study AJNR Am. J. Neuroradiol., November 1, 2001; 22(10): 1915 - 1919. [Abstract] [Full Text] [PDF]
|
|